Pub Date : 2021-10-02DOI: 10.1007/s40506-021-00254-9
J. Mylotte
{"title":"Models for Assessing Severity of Illness in Patients with Bloodstream Infection: a Narrative Review","authors":"J. Mylotte","doi":"10.1007/s40506-021-00254-9","DOIUrl":"https://doi.org/10.1007/s40506-021-00254-9","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 1","pages":"153 - 164"},"PeriodicalIF":0.0,"publicationDate":"2021-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49060240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-08-02DOI: 10.1007/s40506-021-00252-x
Kareshma Mohanty, H. W. Cheung, K. Stafford, D. Riedel
{"title":"Care Outcomes in People Living with HIV and Cancer","authors":"Kareshma Mohanty, H. W. Cheung, K. Stafford, D. Riedel","doi":"10.1007/s40506-021-00252-x","DOIUrl":"https://doi.org/10.1007/s40506-021-00252-x","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 1","pages":"83 - 99"},"PeriodicalIF":0.0,"publicationDate":"2021-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48571535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-01DOI: 10.1007/s40506-021-00251-y
D. Palacio, Katya Prakash, D. Riedel
{"title":"Review of Intravesicular Cidofovir for BK Virus Hemorrhagic Cystitis","authors":"D. Palacio, Katya Prakash, D. Riedel","doi":"10.1007/s40506-021-00251-y","DOIUrl":"https://doi.org/10.1007/s40506-021-00251-y","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 1","pages":"100 - 110"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48747579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-06-25DOI: 10.1007/s40506-021-00250-z
Ashka Patel, J. Bork, D. Riedel
{"title":"Salvage Therapy for the Treatment of Mucormycosis","authors":"Ashka Patel, J. Bork, D. Riedel","doi":"10.1007/s40506-021-00250-z","DOIUrl":"https://doi.org/10.1007/s40506-021-00250-z","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 1","pages":"111 - 122"},"PeriodicalIF":0.0,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-021-00250-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42384603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-08DOI: 10.1007/s40506-021-00246-9
D. A. van de Vijver, Shreoshee Mukherjee, J. V. van Kampen
{"title":"Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis","authors":"D. A. van de Vijver, Shreoshee Mukherjee, J. V. van Kampen","doi":"10.1007/s40506-021-00246-9","DOIUrl":"https://doi.org/10.1007/s40506-021-00246-9","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 1","pages":"141-152"},"PeriodicalIF":0.0,"publicationDate":"2021-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-021-00246-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44596879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-04DOI: 10.1007/s40506-020-00245-2
A. Kołakowska, A. Maresca, I. Collins, J. Cailhol
{"title":"Correction to: Update on Adverse Effects of HIV Integrase Inhibitors","authors":"A. Kołakowska, A. Maresca, I. Collins, J. Cailhol","doi":"10.1007/s40506-020-00245-2","DOIUrl":"https://doi.org/10.1007/s40506-020-00245-2","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 1","pages":"32-33"},"PeriodicalIF":0.0,"publicationDate":"2021-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-020-00245-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47217922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-12-28DOI: 10.1007/s40506-021-00256-7
Jacob Pierce, Michael P Stevens
Purpose of review: The purpose of this article is to critically evaluate the available literature on telehealth and antimicrobial stewardship.
Recent findings: There is limited evidence regarding the role of telehealth within the discipline of antimicrobial stewardship. A review of the available literature suggests remote antimicrobial stewardship programs conducted via telehealth can decrease antimicrobial consumption. A direct comparison between traditional antimicrobial stewardship programs and remote antimicrobial stewardship programs is lacking.
Summary: Telehealth is a promising tool for expanding antimicrobial stewardship, especially in small rural or community hospitals. Trust, team, and technology, the three Ts of remote antimicrobial stewardship derived from themes within the available literature, can serve as a framework for developing a remote antimicrobial stewardship program.
{"title":"The Emerging Role of Telehealth in Antimicrobial Stewardship: A Systematic Review and Perspective.","authors":"Jacob Pierce, Michael P Stevens","doi":"10.1007/s40506-021-00256-7","DOIUrl":"https://doi.org/10.1007/s40506-021-00256-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this article is to critically evaluate the available literature on telehealth and antimicrobial stewardship.</p><p><strong>Recent findings: </strong>There is limited evidence regarding the role of telehealth within the discipline of antimicrobial stewardship. A review of the available literature suggests remote antimicrobial stewardship programs conducted via telehealth can decrease antimicrobial consumption. A direct comparison between traditional antimicrobial stewardship programs and remote antimicrobial stewardship programs is lacking.</p><p><strong>Summary: </strong>Telehealth is a promising tool for expanding antimicrobial stewardship, especially in small rural or community hospitals. Trust, team, and technology, the three Ts of remote antimicrobial stewardship derived from themes within the available literature, can serve as a framework for developing a remote antimicrobial stewardship program.</p>","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 4","pages":"175-191"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39867488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-10-14DOI: 10.1007/s40506-021-00255-8
Heather Albert, Diane Heipel, Tushar P Thakre, Olivia Hess, Kaila Cooper, Rachel Pryor, Mark Smallacombe, Charlene Moore, Emily Godbout, Robert Findling, Gonzalo Bearman
Reason for review: The COVID-19 pandemic has affected the way healthcare services are provided and created challenges to the delivery of behavioral health in the inpatient setting. Here, we present our front-line experience of infection prevention for the psychiatric patient in the COVID era.
Recent findings: There are unique challenges surrounding COVID-19 precautions within inpatient psychiatric settings. The challenges presented to psychiatric care by COVID-19 begin in the emergency department and follow the patient through the continuum of care once admitted to the facility. Unit infrastructure, patient population, treatment modalities, staffing considerations, and discharge planning are distinct instances where COVID-19 protocols that are well-suited for other hospital settings necessitate revision for psychiatric settings.
Summary: The purpose of this communication is to add to the current body of shared experience of infection prevention for the psychiatric patient in the COVID-19 era.
{"title":"Management of the COVID-19-Infected Psychiatric Inpatients: Unique Infection Prevention Considerations and Evolving Strategies.","authors":"Heather Albert, Diane Heipel, Tushar P Thakre, Olivia Hess, Kaila Cooper, Rachel Pryor, Mark Smallacombe, Charlene Moore, Emily Godbout, Robert Findling, Gonzalo Bearman","doi":"10.1007/s40506-021-00255-8","DOIUrl":"https://doi.org/10.1007/s40506-021-00255-8","url":null,"abstract":"<p><strong>Reason for review: </strong>The COVID-19 pandemic has affected the way healthcare services are provided and created challenges to the delivery of behavioral health in the inpatient setting. Here, we present our front-line experience of infection prevention for the psychiatric patient in the COVID era.</p><p><strong>Recent findings: </strong>There are unique challenges surrounding COVID-19 precautions within inpatient psychiatric settings. The challenges presented to psychiatric care by COVID-19 begin in the emergency department and follow the patient through the continuum of care once admitted to the facility. Unit infrastructure, patient population, treatment modalities, staffing considerations, and discharge planning are distinct instances where COVID-19 protocols that are well-suited for other hospital settings necessitate revision for psychiatric settings.</p><p><strong>Summary: </strong>The purpose of this communication is to add to the current body of shared experience of infection prevention for the psychiatric patient in the COVID-19 era.</p>","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 4","pages":"165-174"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39555234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose of review: There is a need for enhanced adoption of infection prevention and control (IPC) practices in both healthcare settings and the entire community, more so during pandemics. The exponential increase in the use of social media (SM) has made it a powerful tool for creating awareness, education, training and community engagement on IPC. Here, we review how social media can be used effectively to implement strategies to combat public health issues especially vis-à-vis infection prevention and control.
Recent findings: According to the World Health Organization, 10% of patients get an infection whilst receiving care in healthcare institutions. Effective infection prevention and control measures can reduce healthcare-associated infections by at least 30%. Education and awareness play a vital role in implementation of infection prevention and control (IPC) strategies. Various studies show how social media has been used successfully in education and training activities, for awareness campaigns, community engagement, risk communications during outbreaks, disease surveillance and pharmacovigilance.
Summary: Infection prevention and control (IPC) is the need of the hour to mitigate transmission of disease in healthcare settings as well as in the community. SM is the fastest and most efficient way of communicating with the general population as well as health professionals. SM can help people take the right decisions and enable change in their behaviour patterns to introduce infection control practices.
{"title":"Use of \"Social Media\"-an Option for Spreading Awareness in Infection Prevention.","authors":"Jayaprakasam Madhumathi, Rina Sinha, Balaji Veeraraghavan, Kamini Walia","doi":"10.1007/s40506-020-00244-3","DOIUrl":"https://doi.org/10.1007/s40506-020-00244-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>There is a need for enhanced adoption of infection prevention and control (IPC) practices in both healthcare settings and the entire community, more so during pandemics. The exponential increase in the use of social media (SM) has made it a powerful tool for creating awareness, education, training and community engagement on IPC. Here, we review how social media can be used effectively to implement strategies to combat public health issues especially vis-à-vis infection prevention and control.</p><p><strong>Recent findings: </strong>According to the World Health Organization, 10% of patients get an infection whilst receiving care in healthcare institutions. Effective infection prevention and control measures can reduce healthcare-associated infections by at least 30%. Education and awareness play a vital role in implementation of infection prevention and control (IPC) strategies. Various studies show how social media has been used successfully in education and training activities, for awareness campaigns, community engagement, risk communications during outbreaks, disease surveillance and pharmacovigilance.</p><p><strong>Summary: </strong>Infection prevention and control (IPC) is the need of the hour to mitigate transmission of disease in healthcare settings as well as in the community. SM is the fastest and most efficient way of communicating with the general population as well as health professionals. SM can help people take the right decisions and enable change in their behaviour patterns to introduce infection control practices.</p>","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 1","pages":"14-31"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-020-00244-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25314421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-05-17DOI: 10.1007/s40506-021-00248-7
Tara M Babu, Camille N Kotton
Purpose of review: Infection is a significant cause of morbidity and mortality in both patients with chronic kidney disease (CKD) and in recipients of a kidney transplant (KT). We review the current data in patients with CKD, on dialysis, and in KT recipients to provide further guidance for clinicians regarding vaccine optimization in this patient population.
Recent findings: This patient population remains under-vaccinated and thus more vulnerable to vaccine-preventable illness. Despite diminished responses to immunization in this population, significant protection is generally achieved.
Summary: Vaccines are an important preventative tool and offer protection against infection. In the setting of suboptimal and waning immunity in this patient population, future studies are indicated to determine optimal vaccination regimens.
{"title":"Immunizations in Chronic Kidney Disease and Kidney Transplantation.","authors":"Tara M Babu, Camille N Kotton","doi":"10.1007/s40506-021-00248-7","DOIUrl":"10.1007/s40506-021-00248-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Infection is a significant cause of morbidity and mortality in both patients with chronic kidney disease (CKD) and in recipients of a kidney transplant (KT). We review the current data in patients with CKD, on dialysis, and in KT recipients to provide further guidance for clinicians regarding vaccine optimization in this patient population.</p><p><strong>Recent findings: </strong>This patient population remains under-vaccinated and thus more vulnerable to vaccine-preventable illness. Despite diminished responses to immunization in this population, significant protection is generally achieved.</p><p><strong>Summary: </strong>Vaccines are an important preventative tool and offer protection against infection. In the setting of suboptimal and waning immunity in this patient population, future studies are indicated to determine optimal vaccination regimens.</p>","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"13 2","pages":"47-65"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38940227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}